Author： Johansson C. Jansson M. Linner L. Yuan Q.-P. Pedersen N.L. Blackwood D. Barden N. Kelsoe J. Schalling M.
Publisher： Elsevier
ISSN： 0924-977X
Source： European Neuropsychopharmacology, Vol.11, Iss.6, 2001-12, pp. : 385-394
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Olanzapine in Schizophrenia and Affective Disorders
Drug Safety, Vol. 35, Iss. 12, 2012-12 ,pp. :
Access to resources
Recommend
Pharmacogenetics in affective disorders
By Serretti A. Lilli R. Smeraldi E.
European Journal of Pharmacology, Vol. 438, Iss. 3, 2002-03 ,pp. :
Anabolic steroid abuse: Affective disorders: case report
Reactions Weekly, Vol. 1, Iss. 1148, 2007-01 ,pp. :
Affective and Anxiety Disorders in Patients with Cancer: Optimal Management
By Ronson A.
CNS Drugs, Vol. 12, Iss. 2, 1999-08 ,pp. :
Pharmacogenetics in Affective Disorders: A Drug Response Approach
Current Pharmacogenomics, Vol. 4, Iss. 3, 2006-09 ,pp. :